Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Blood

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Blood|March 19, 2016
Less menorrhagia for women with VTESam Schulman
Blood|January 4, 2024
CHC and surgery: when is stopping safe?Sam Schulman
Blood|May 10, 2017
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapySam Schulman
Blood|December 19, 2018
Treatment of bleeding complications in patients on anticoagulant therapySiavash Piran, Sam Schulman
Blood|February 4, 2012
How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switchSam Schulman, Mark A Crowther
Blood|March 21, 2002
Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?Johanna S Ungerstedt, Sam Schulman, Nils Egberg, et al.
Blood|June 26, 2014
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trialsNick van Es, Michiel Coppens, Sam Schulman, et al.
Blood|August 25, 2017
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort studyAmmar Majeed, Anna Ågren, Margareta Holmström, et al.
Blood|March 20, 2010
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based studySigurdur Y Kristinsson, Ruth M Pfeiffer, Magnus Björkholm, et al.
Blood|November 12, 2010
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO modelNeil A Goldenberg, Alex C Spyropoulos, Jonathan L Halperin, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Blood|March 19, 2016
Less menorrhagia for women with VTESam Schulman
Blood|January 4, 2024
CHC and surgery: when is stopping safe?Sam Schulman
Blood|May 10, 2017
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapySam Schulman
Blood|December 19, 2018
Treatment of bleeding complications in patients on anticoagulant therapySiavash Piran, Sam Schulman
Blood|February 4, 2012
How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switchSam Schulman, Mark A Crowther
Blood|March 21, 2002
Discrepancy between antithrombin activity methods revealed in Antithrombin Stockholm: do factor Xa-based methods overestimate antithrombin activity in some patients?Johanna S Ungerstedt, Sam Schulman, Nils Egberg, et al.
Blood|June 26, 2014
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trialsNick van Es, Michiel Coppens, Sam Schulman, et al.
Blood|August 25, 2017
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort studyAmmar Majeed, Anna Ågren, Margareta Holmström, et al.
Blood|March 20, 2010
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based studySigurdur Y Kristinsson, Ruth M Pfeiffer, Magnus Björkholm, et al.
Blood|November 12, 2010
Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO modelNeil A Goldenberg, Alex C Spyropoulos, Jonathan L Halperin, et al.
Pageof 2